Introduction
Definitive diagnosis of prosthetic valve endocarditis (PVE) is clinically challenging because of its varying clinical presentation, microorganisms involved and patient profile. Prosthetic valve endocarditis entails high initial mortality and morbidity rates with a high risk of complications, including perivalvular abscess and fistulae during follow-up and often requires surgical intervention. 1 Therefore, the diagnosis and management of PVE necessitates a collaborative approach involving cardiologists, infectious disease physicians, cardiac imaging specialists, cardiovascular surgeons, and microbiologists. 2 Recently, 18 F-fluorodeoxyglucose positron emission tomography/computed tomography ( 18 F-FDG PET/CT) has been advocated as an alternative diagnostic imaging modality for PVE, particularly when echocardiography and blood culture results are inconclusive in reaching a definitive PVE diagnosis. 3 Furthermore, 18 F-FDG PET/CT can detect distant emboli, metastatic infections and perivalvular involvement along with coronary anatomy when combined with CT coronary angiography. 4 Additionally, complementary information obtained from less invasive tests are vital for patients with PVE who require early surgery. Herein, we present a challenging case of PVE complicated with perivalvular abscess.
Timeline

Case presentation
A 64-year-old man presented to our outpatient clinic with complaints of general fatigue and high fever (>38 C) at night that persisted for 3 days. He had previously undergone 25-mm mechanical aortic valve implantation (St. Jude Medical Regent; St. Jude Medical, Inc., St. Paul, MN) 12 years prior because of severe aortic regurgitation. Upon examination, no focus of infection could be identified, and he was admitted to our heart centre to exclude the possibility of PVE. After three sets of blood culture were obtained, intravenous ceftriaxone (2 g/day) was empirically initiated. Initial transthoracic echocardiography (TTE) revealed no dysfunction of the mechanical aortic prosthesis, and whole-body CT revealed no embolic events. The patient recovered to a low-grade fever (37-38 C) 48 h after the initial antibiotics therapy and showed improved C-reactive protein level (from 13 to 6.3 mg/dL) in the first 5 days. Subsequently, transoesophageal echocardiography (TOE) performed on the 5th day of hospitalization revealed a 6-11 mm mobile echogenic mass attached to the prosthetic valve and a thickened area within the posterior annular region with a low echogenic appearance at the level of the noncoronary sinus of Valsalva (Figure 1 ). At this point, the patient met two minor diagnostic criteria (predisposing heart condition of prior prosthetic valve implantation and high fever) in the modified Duke diagnostic criteria for infective endocarditis because the TOE findings were considered inconclusive. Subsequently, combined 18 F-FDG PET/CT and CT coronary angiography revealed intense hypermetabolism above the aortic valve prosthesis with greater intensity at 12 years before admission 25-mm mechanical aortic valve implantation owing to severe aortic regurgitation. 3 days before admission Fever at night and general fatigue initiated.
Day of admission
Initial transthoracic echocardiography revealed no dysfunction of the mechanical aortic prosthesis, and no embolic events were detected on the whole-body computed tomography (CT). Three blood culture tests were performed and intravenous antibiotic therapy with ceftriaxone (2 g/day) was initiated.
Hospital Day 5
Transoesophageal echocardiography was inconclusive and fever persisted.
Hospital Day 8
All blood culture tests were negative. 18 F-fluorodeoxyglucose (FDG) positron emission tomography/CT revealed considerable uptake of 18 F-FDG surrounding the aortic annulus; intensive antibiotic therapy was initiated with intravenous ampicillin (8 g/day) and gentamicin (180 mg/day).
Hospital Day 14
The infected prosthetic valve was surgically replaced with a 25-mm bioprosthesis with extensive debridement of perivalvular abscess.
Hospital Day 51
The patient was discharged well.
6 months after discharge A 6-month of outpatient oral antibiotic therapy with amoxicillin (750 mg/day) was completed without any recurrences. the posterior end and absence of obstructive coronary artery, thereby confirming the diagnosis of aortic PVE complicated with perivalvular abscess (Figure 2) . Following a comprehensive discussion with the endocarditis team, including an infectious disease specialist, a microbiologist (pathologist) and cardiovascular surgeons, we decided to switch from intravenous ceftriaxone to appropriate antibiotic therapy [intravenous ampicillin (8 g/day) and gentamicin (180 mg/day)] for blood culture-negative patients with PVE based on the current ESC guideline 5 and withheld specific serological tests or polymerase chain reaction (PCR) assays for unusual but potential microorganisms as long as the patient's clinical course was not out of track and the antibiotics therapy appeared clinically effective. Following 1 week of intensive antibiotic treatment, we finally decided to perform surgery mainly because the PVE was complicated with perivalvular abscess, as evidenced by 18 F-FDG PET/CT with all negative blood culture tests.
On the 14th day of hospitalization, prosthetic valve was surgically replaced with a 25-mm bioprosthesis (25A Trifecta TM ; St. Jude Medical, Inc., St. Paul, MN, USA) with extensive debridement of the infected and necrotic tissues surrounding the aortic annulus ( Figure  3A and B) . Surgically excised tissue was subjected to microbiological and pathological analysis; however, no evidence of bacterial organisms was found ( Figure 3C and D) and blood culture tests were negative. Post-operative TTE revealed a normally functioning aortic valve, and he was discharged on the 51st day. Based on the international guideline, 5 antibiotic therapy was continued for 6 weeks until hospital discharge, although gentamicin was discontinued in the first 3 weeks because of nephrotoxicity. Furthermore, intravenous antibiotic treatment was followed by 6-month outpatient oral antibiotic therapy with amoxicillin (750 mg/day) without any recurrences.
Discussion
The modified Duke criteria have been recommended for PVE diagnosis since its proposal by Durack et al. 6 Notwithstanding the presence of well-established clinical criteria, PVE diagnosis poses some challenges. There is a common concern regarding the interpretation of echocardiographic findings, despite TTE or TOE being the primary diagnostic approach. 7 As observed in the patient in this study, echocardiographic findings can often be inconclusive, which can be primarily attributed to the similar appearance of both the thrombus and pannus on the prosthetic valves, which cannot be distinguished from vegetation. 7 This inconclusive diagnosis can lead to difficulty or delay in surgical decisions, particularly in patients with low-to-intermediate likelihood of PVE, such as those with negative blood culture tests. 18 F-fluorodeoxyglucose positron emission tomography/computed tomography is an established diagnostic modality in patients with suspected PVE that is used when conventional diagnostic tools fail to provide a definitive diagnosis. 5 In the present patient, perivalvular involvement was a key observation because intense 18 FDG uptake confined to the aortic annulus above the prosthesis as revealed by 18 F-FDG PET/CT images was compatible with the thickened area within the aortic annular region observed in TOE examinations, implying perivalvular abscess formation. Additionally, detecting perivalvular involvement by utilizing 18 F-FDG PET/CT allowed us to improve the diagnostic accuracy of PVE.
As a preoperative risk assessment, CT angiography is more advantageous and safer than invasive coronary angiography in PVE cases involving the aortic valve because invasive coronary angiography potentially involves risks of vegetation embolization or haemodynamic decompensation. Also, CT angiography can provide further information on the valve size, anatomy, and calcification of aortic valve, which are essential for surgical planning. 8 Furthermore, compared with the TOE findings, the combination of PET and CT angiography enhances the accuracy of identification of the infected location, in addition to the delineation of coronary anatomy and detection of fistulae and abscess, distal embolic complications and infected aneurysms at other sites. 4 Another important case discussion was on how to manage the blood culture-negative patient with PVE with appropriate antibiotic therapy and/or surgical intervention if needed. The patient was initially treated with ceftriaxone in empirical therapy for unexplained fever following three sets of blood culture tests. Although the patient's condition stabilised in the first week, with improvement in fever and general appearance, we switched ceftriaxone to intravenous ampicillin and gentamicin because the findings of 18 F-FDG PET/CT imaging were highly suggestive of PVE. These antibiotic regimens for initial empirical treatment of late PVE were determined based on the current ESC guideline 5 and consultation with the endocarditis team. In a recent review, 9 Viridans group streptococci, coagulase-negative staphylococci (CNS), Enterococcus spp. and Streptococcus bovis were reported to be the most common pathogens in patients with PVE. We carefully selected a combination of ampicillin and gentamicin to mainly treat staphylococci, streptococci, and enterococci. We assumed that the patient's clinical course was relatively subacute and less destructive with no major complications such as heart failure and systematic embolism and ceftriaxone seemed to be clinically effective. Considering this, PVE triggered by Staphylococcus aureus or CNS was slightly less likely to occur in the patient. Blood culture-negative infective endocarditis (BCNIE) can be caused by fungi or fastidious slow-growing bacteria, notably obligatory intracellular bacteria. 1 Among them, 
